MHRA approves imlunestrant tosylate as new breast cancer treatment
25th February 2026 Uncategorised 0
Oral therapy authorised for ER‑positive, HER2‑negative metastatic disease with ESR1 mutations

More: MHRA approves imlunestrant tosylate as new breast cancer treatment
Source: News
